Thursday, June 24, 2010

• New CDC Guidelines Prefer Use of Blood Tests, Including QuantiFERON®-TB, to Diagnose Tuberculosis Infection in Certain Populations --- VALENCIA, Calif., June 24
  Posted at 1:37 PM
  Today the United States (U.S.) Centers for Disease Control and Prevention (CDC) issued new and important guidelines on the detection of Mycobacterium tuberculosis infections, the causative agent of tuberculosis (TB). In these landmark guidelines, CDC advises that Interferon Gamma Release Assay (IGRA) blood tests are now preferred over the 100+-year-old tuberculin skin test (TST) for diagnosing TB infection in certain populations, including people who typically do not return for the necessary reading of TST results, and those who have received ... read more
• Partner Communications Announces the Submission of Its Position to the Ministry of Communications' Hearing Regarding Interconnect Tariffs Reduction and Its Possible Implications --- ROSH HA'AYIN, Israel
  Posted at 1:35 PM
  

  Partner Communications Company Ltd. ("Partner" or "the Company") (Nasdaq:PTNR)(TASE:PTNR), a leading Israeli communications operator, announces, following its press releases dated May 4, 2010 and May 5, 2010, that the Company has submitted today, June 24, 2010, its position with respect to the hearing that the Ministry ... read more
• InformationWeek Analytics New Research Finds Nearly 70% of Respondents Will Calculate the ROI of Cloud Computing --- SAN FRANCISCO, June 24
  Posted at 1:31 PM
  InformationWeek Analytics, the leading service for peer-based IT research and analysis, today announced the release of its research report: Cloud ROI: Calculating Costs, Benefits, Returns, including exclusive analysis of the approach respondents' organizations use to quantify risks (such as project failure or budget overruns) as cash flow in an ROI analysis. Nearly 400 business technology professionals weighed in on how they weigh costs of outsourcing vs. on-premises delivery of IT services. The report author, Jonathan Feldman, is the director of ... read more
• UBM Everything Channel's Virtual Trade Show Brought Technology Vendors and Solution Providers Together to Discuss How to Win with Emerging Technologies --- CHICAGO, June 24
  Posted at 1:30 PM
  Solution Providers are driving a higher percentage of their sales and profits from emerging vendors across the board. UBM Everything Channel's virtual trade show highlights technology channel opportunities in the emerging market. The virtual event created by UBM Studios provided a 3D interface facilitating online interaction between vendors and solution providers took place Wednesday, June 23, 2010 from 11 AM - 5 PM Eastern. (Photo: http://photos.prnewswire.com/prnh/20100624/NY26449 ) (Photo: http://www.newscom.com/cgi-bin/prnh/20100624/NY26449 ) This virtual event, How to Win with Emerging Technologies, highlighted several ... read more
• Jazz Pharmaceuticals' JZP-6 to be Reviewed at a Joint Meeting of the FDA's Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee on August 20, 2010 --- PALO ALTO, Calif., June 24
  Posted at 1:30 PM
  Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that the U.S. Food and Drug Administration's (FDA) Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee will review JZP-6 (sodium oxybate) for the treatment of fibromyalgia at a joint meeting on August 20, 2010. In February 2010, the FDA accepted for filing and review the New Drug Application (NDA) of JZP-6 (sodium oxybate) for the treatment of fibromyalgia. The target date for the FDA to complete its review of ... read more
• DEI Holdings Charitable Foundation Announces Two Major Fundraisers in August --- VISTA, Calif., June 24
  Posted at 1:30 PM
  The DEI Holdings Charitable Foundation, a not-for-profit 501(c)(3) organization whose mission is: "To improve the quality of life for disadvantaged children in the communities in which we do business," is pleased to announce two major fundraising events happening in August which are both open to the general public: Charity Gala Dinner: To be held on Sunday night August 22 at the Sheraton Carlsbad Resort & Spa, the DEI Holdings Charity Gala will honor Darrell & Kathy Issa for their many charitable ... read more
• Allscripts to Announce Fiscal Fourth Quarter and Year-End Results --- CHICAGO, June 24
  Posted at 1:30 PM
  Allscripts (Nasdaq: MDRX) announced today that it will report its financial results for the three months and fiscal year ended May 31, 2010 after the stock market closes on Tuesday, July 20, 2010. Allscripts management will host a conference call and webcast to discuss the company's earnings and other information at 4:30 PM Eastern Daylight Time on the same day. (Logo: http://photos.prnewswire.com/prnh/20081013/AQM041LOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO) The earnings announcement will be distributed via PR Newswire immediately after the market closes on ... read more
• Socialtext Hires SaaS Veteran Brian Bailard as Vice President of Sales --- PALO ALTO, Calif.
  Posted at 1:29 PM
  

  Socialtext today announced the addition of Brian Bailard as the company's new Vice President of Sales. Bailard brings more than 20 years of experience in sales leadership and executive management at firms focused on cloud computing, software as a service (SaaS) and online marketing. Bailard ... read more
• National HIV Testing Day: The Day After --- WASHINGTON, June 24
  Posted at 1:22 PM
  National HIV Testing Day is June 27, 2010. Like every day in a country where there are 56,000 new HIV infections a year, approximately 150 Americans will learn of their HIV infection on June 27th. So, here's the question -- what happens on June 28th, the day after National HIV Testing Day? What do medical providers do with these newly-identified HIV patients? "Linkage to care remains a significant problem for HIV testing efforts," stated American Academy of HIV Medicine Executive ... read more
• Pfizer Declares An 18-Cent Third-Quarter 2010 Dividend --- NEW YORK, June 24
  Posted at 1:15 PM
  The board of directors of Pfizer Inc. (NYSE: PFE) today declared an 18-cent third-quarter 2010 dividend on the company's common stock, payable September 1, 2010, to shareholders of record at the close of business on August 6, 2010. (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20100416/PFIZERLOGO ) The third-quarter 2010 cash dividend will be the 287th consecutive quarterly dividend paid by Pfizer. SOURCE Pfizer Inc. ... read more
• Sears Provides Even More Convenience and Choice to Puerto Rico Customers --- HOFFMAN ESTATES, Ill. and SAN JUAN, Puerto Rico, June 24
  Posted at 1:11 PM
  After serving generations of customers in Puerto Rico through its stores, home services and licensed businesses, Sears Holdings is proud to announce the launch of Searspr.com, the island's first transactional website by a major U.S. retailer designed to cater specifically to the Puerto Rico market. By developing and launching this exciting new website, Sears is providing customers in Puerto Rico with the power of choice - the choice to determine how they want to shop - either online or in-store ... read more
• P&G Voluntarily Recalls 4 Hour Decongestant Nasal Spray in the United States --- CINCINNATI, June 24, 2010
  Posted at 1:05 PM
  The Procter & Gamble Company (NYSE: PG) announced today it is voluntarily recalling its 4-Hour Decongestant Nasal Spray. The product was distributed nationwide in the United States. To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/pg/44953/ The company said it is taking this voluntary precautionary step after finding that the product formulation may not meet the expiration dates on the package. This recall is not a result of consumer complaints. P&G is removing the product in question from ... read more
• Blockbuster Announces Preliminary Results from Shareholder Voting --- DALLAS, June 24
  Posted at 1:01 PM
  Blockbuster Inc. (NYSE: BBI, BBI.B) today announced the preliminary shareholder voting results at the company annual shareholders meeting in Dallas. Blockbuster shareholders overwhelmingly approved combining Class A common stock and Class B common stock into a single stock. Shareholders also approved the option for a reverse stock split as part of the company's compliance plan with the New York Stock Exchange. Additionally, named to the company's board of directors by shareholder voting and company agreement were: -- ... read more
• Danaher Schedules Second Quarter Earnings Conference Call --- WASHINGTON, June 24
  Posted at 1:00 PM
  Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter of 2010 on Thursday, July 22, 2010 beginning at 8:00 a.m. EDT and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on Danaher's website at www.danaher.com. You can access a replay of the webcast on the "Investors" section of Danaher's website (under the subheading "Investor Events") shortly after the conclusion of the presentation, and the webcast ... read more
• GlycoMimetics Initiates Phase 2 Clinical Trial of Lead Candidate GMI-1070 in Sickle Cell Patients --- GAITHERSBURG, Md.
  Posted at 12:56 PM
  

  GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the commencement of a Phase 2 clinical trial of GMI-1070 for treatment of vaso-occlusive crisis of sickle cell disease. The company also announced that GMI-1070 ... read more
• Industrial Biotech Companies to Showcase Biobased Products at World Congress on Industrial Biotechnology & Bioprocessing
  Posted at 12:47 PM
  

  BIO:   ... read more
• Critical Path Institute’s Predictive Safety Testing Consortium (PSTC) Announces First-Ever Biomarker Qualification Decision by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) --- TUCSON, Ariz.
  Posted at 12:39 PM
  

  For the first time, new biomarker tests to detect drug-induced kidney injury have been accepted by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). Critical Path Institute’s (C-Path) Predictive Safety Testing Consortium (PSTC) submitted the data for seven urinary protein biomarkers (KIM-1, Albumin, Total Protein, β2-microglobulin, ... read more
• CelleBrite Releases Native Support for iPhone 4 --- GLEN ROCK, N.J., June 24
  Posted at 12:38 PM
  CelleBrite, providing the tools, technology and talent to optimize mobile device-driven data, today announced that its Universal Memory Exchanger (UME-36Pro) is the first tested and proven mobile data synchronization and backup solution to offer native support for Apple's iPhone 4. Carriers and retailers selling the latest iteration of Apple's smartphone now possess a powerful solution for seamlessly transferring subscribers', contacts, phonebook, photos and other data at the point-of-sale (POS) without the need for a PC or additional software. ... read more
• For Guests at Shutters on the Beach, iPad is Now Your Pad --- SANTA MONICA, Calif., June 24
  Posted at 12:37 PM
  Available to vacationers for the first time, guests staying in any of the Premier suites at famed Shutters on the Beach, will be presented with their very own iPad, available for use throughout their stay at no cost or rental fee. The hotel is completely Wi-Fi enabled, so the iPad can travel with the guest wherever they may go on the property. The iPads have been outfitted with the Shutters touch and will include applications and features that will ... read more
• FAA Selects Pratt & Whitney for CLEEN Technologies Program, Targets the Environmentally-Friendly PurePower® Engines --- WASHINGTON, June 24
  Posted at 12:35 PM
  The Federal Aviation Administration (FAA) announced today that Pratt & Whitney has been awarded a one-year contract with extension options, which will assist Pratt & Whitney to further develop and mature new jet engine technologies aimed at reduced fuel burn, noise and emissions under the FAA's Continuous Lower Energy, Emissions and Noise (CLEEN) technology development program. The funding will support ongoing development of advanced technologies for the new game-changing PurePower engine family with the geared turbofan(TM) architecture. Pratt ... read more